Reinstatement with change of a previously approved collection
No
Regular
05/02/2025
Requested
Previously Approved
36 Months From Approved
74,375,565,700
0
2,550,820
0
0
0
This information collection implements
the Drug Supply Chain Security Act. Manufacturers, repackagers,
wholesale distributors, and dispensers must: (1) Notify FDA when
they have determined that a product in their possession or control
is illegitimate or if a manufacturer when they determine that a
product has a high risk of illegitimacy; (2) terminate such
notifications after consultation with FDA; (3) notify certain
immediate trading partners about an illegitimate product or if a
manufacturer about a product with a high risk of illegitimacy; and
(4) notify immediate trading partners when such notifications are
terminated.
US Code:
21
USC 360eee Name of Law: Drug Supply Chain Security Act
Our estimated burden for the
information collection reflects some significant increases; most
notably burden we attribute to the task of documenting individual
transaction information. We have also increased the number of
respondents submitting WEE requests in response to public comment
and as discussed at Q-12 of our SSA. We also note significant
ongoing recordkeeping attributable to documenting activities along
the supply chain that we regard as usual and customary in complying
with the self-executing requirements of Drug Supply Chain Security
Act set forth in sections 581 and 581 (Subchapter H –
Pharmaceutical Distribution Supply Chain) of the FD&C Act.
$3,800
No
Yes
No
No
No
No
No
Domini Bean 301 796-5733
domini.bean@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.